-
1
-
-
77954177555
-
Preconditioning and postinsult therapies for perinatal hypoxic-ischemic injury at term
-
Sanders RD, Manning HJ, Robertson NJ, Ma D, Edwards AD, et al. (2010) Preconditioning and postinsult therapies for perinatal hypoxic-ischemic injury at term. Anesthesiology 113: 233-249.
-
(2010)
Anesthesiology
, vol.113
, pp. 233-249
-
-
Sanders, R.D.1
Manning, H.J.2
Robertson, N.J.3
Ma, D.4
Edwards, A.D.5
-
2
-
-
33644528136
-
Neuroprotective effect of selective kappa opioid receptor agonist is gender specific and linked to reduced neuronal nitric oxide
-
Zeynalov E, Nemoto M, Hurn PD, Koehler RC, Bhardwaj A, (2006) Neuroprotective effect of selective kappa opioid receptor agonist is gender specific and linked to reduced neuronal nitric oxide. J Cereb Blood Flow Metab 26: 414-420.
-
(2006)
J Cereb Blood Flow Metab
, vol.26
, pp. 414-420
-
-
Zeynalov, E.1
Nemoto, M.2
Hurn, P.D.3
Koehler, R.C.4
Bhardwaj, A.5
-
3
-
-
33749471577
-
Opioid preconditioning induces opioid receptor-dependent delayed neuroprotection against ischemia in rats
-
Zhao P, Huang Y, Zuo Z, (2006) Opioid preconditioning induces opioid receptor-dependent delayed neuroprotection against ischemia in rats. J Neuropathol Exp Neurol 65: 945-952.
-
(2006)
J Neuropathol Exp Neurol
, vol.65
, pp. 945-952
-
-
Zhao, P.1
Huang, Y.2
Zuo, Z.3
-
4
-
-
34547871256
-
Dose-dependent neuroprotection of delta opioid peptide [D-Ala2, D-Leu5] enkephalin in neuronal death and retarded behavior induced by forebrain ischemia in rats
-
Su DS, Wang ZH, Zheng YJ, Zhao YH, Wang XR, (2007) Dose-dependent neuroprotection of delta opioid peptide [D-Ala2, D-Leu5] enkephalin in neuronal death and retarded behavior induced by forebrain ischemia in rats. Neurosci Lett 423: 113-117.
-
(2007)
Neurosci Lett
, vol.423
, pp. 113-117
-
-
Su, D.S.1
Wang, Z.H.2
Zheng, Y.J.3
Zhao, Y.H.4
Wang, X.R.5
-
5
-
-
0021684695
-
Dynorphin (1-13) improves survival in cats with focal cerebral ischaemia
-
Baskin DS, Hosobuchi Y, Loh HH, Lee NM, (1984) Dynorphin (1-13) improves survival in cats with focal cerebral ischaemia. Nature 312: 551-552.
-
(1984)
Nature
, vol.312
, pp. 551-552
-
-
Baskin, D.S.1
Hosobuchi, Y.2
Loh, H.H.3
Lee, N.M.4
-
6
-
-
0023764133
-
Quantitative analysis of effects of kappa-opioid agonists on postischemic hippocampal CA1 neuronal necrosis in gerbils
-
Hall ED, Pazara KE, (1988) Quantitative analysis of effects of kappa-opioid agonists on postischemic hippocampal CA1 neuronal necrosis in gerbils. Stroke 19: 1008-1012.
-
(1988)
Stroke
, vol.19
, pp. 1008-1012
-
-
Hall, E.D.1
Pazara, K.E.2
-
7
-
-
0037637597
-
Neuroprotective kappa-opioid receptor agonist BRL 52537 attenuates ischemia-evoked nitric oxide production in vivo in rats
-
Goyagi T, Toung TJ, Kirsch JR, Traystman RJ, Koehler RC, et al. (2003) Neuroprotective kappa-opioid receptor agonist BRL 52537 attenuates ischemia-evoked nitric oxide production in vivo in rats. Stroke 34: 1533-1538.
-
(2003)
Stroke
, vol.34
, pp. 1533-1538
-
-
Goyagi, T.1
Toung, T.J.2
Kirsch, J.R.3
Traystman, R.J.4
Koehler, R.C.5
-
8
-
-
0344851894
-
Kappa-opioid receptor selectivity for ischemic neuroprotection with BRL 52537 in rats
-
Zhang Z, Chen TY, Kirsch JR, Toung TJ, Traystman RJ, et al. (2003) Kappa-opioid receptor selectivity for ischemic neuroprotection with BRL 52537 in rats. Anesth Analg 97: 1776-1783.
-
(2003)
Anesth Analg
, vol.97
, pp. 1776-1783
-
-
Zhang, Z.1
Chen, T.Y.2
Kirsch, J.R.3
Toung, T.J.4
Traystman, R.J.5
-
9
-
-
79952990032
-
Opioid receptor agonists reduce brain edema in stroke
-
Yang L, Wang H, Shah K, Karamyan VT, Abbruscato TJ, (2011) Opioid receptor agonists reduce brain edema in stroke. Brain Research 1383: 307-316.
-
(2011)
Brain Research
, vol.1383
, pp. 307-316
-
-
Yang, L.1
Wang, H.2
Shah, K.3
Karamyan, V.T.4
Abbruscato, T.J.5
-
10
-
-
38849095818
-
Neuroprotection and functional recovery conferred by administration of kappa- and delta 1-opioid agonists in a rat model of global ischemia
-
Charron C, Messier C, Plamondon H, (2008) Neuroprotection and functional recovery conferred by administration of kappa- and delta 1-opioid agonists in a rat model of global ischemia. Physiol behav 93: 502-511.
-
(2008)
Physiol Behav
, vol.93
, pp. 502-511
-
-
Charron, C.1
Messier, C.2
Plamondon, H.3
-
11
-
-
80054791798
-
Duration of action of a broad range of selective kappa-opioid receptor antagonists is positively correlated with c-Jun N-terminal kinase-1 activation
-
Melief EJ, Miyatake M, Carroll FI, Beguin C, Carlezon WA, et al. (2011) Duration of action of a broad range of selective kappa-opioid receptor antagonists is positively correlated with c-Jun N-terminal kinase-1 activation. Mol pharmacol 80: 920-929.
-
(2011)
Mol Pharmacol
, vol.80
, pp. 920-929
-
-
Melief, E.J.1
Miyatake, M.2
Carroll, F.I.3
Beguin, C.4
Carlezon, W.A.5
-
12
-
-
79251638019
-
Salvinorin A produces cerebrovasodilation through activation of nitric oxide synthase, kappa receptor, and adenosine triphosphate-sensitive potassium channel
-
Su D, Riley J, Kiessling WJ, Armstead WM, Liu R, (2011) Salvinorin A produces cerebrovasodilation through activation of nitric oxide synthase, kappa receptor, and adenosine triphosphate-sensitive potassium channel. Anesthesiology 114: 374-379.
-
(2011)
Anesthesiology
, vol.114
, pp. 374-379
-
-
Su, D.1
Riley, J.2
Kiessling, W.J.3
Armstead, W.M.4
Liu, R.5
-
13
-
-
84856712415
-
Dynamic cerebral autoregulation associates with infarct size and outcome after ischemic stroke
-
Reinhard M, Rutsch S, Lambeck J, Wihler C, Czosnyka M, et al. (2012) Dynamic cerebral autoregulation associates with infarct size and outcome after ischemic stroke. Acta Neurol Scand 125: 156-62.
-
(2012)
Acta Neurol Scand
, vol.125
, pp. 156-162
-
-
Reinhard, M.1
Rutsch, S.2
Lambeck, J.3
Wihler, C.4
Czosnyka, M.5
-
14
-
-
0036216465
-
Dynamic cerebral autoregulation and beat to beat blood pressure control are impaired in acute ischaemic stroke
-
Eames PJ, Blake MJ, Dawson SL, Panerai RB, Potter JF, (2002) Dynamic cerebral autoregulation and beat to beat blood pressure control are impaired in acute ischaemic stroke. J Neurol Neurosurg Psychiatry 72: 467-472.
-
(2002)
J Neurol Neurosurg Psychiatry
, vol.72
, pp. 467-472
-
-
Eames, P.J.1
Blake, M.J.2
Dawson, S.L.3
Panerai, R.B.4
Potter, J.F.5
-
15
-
-
0038316510
-
Serial changes in static and dynamic cerebral autoregulation after acute ischaemic stroke
-
Dawson SL, Panerai RB, Potter JF, (2003) Serial changes in static and dynamic cerebral autoregulation after acute ischaemic stroke. Cerebrovasc Dis 16: 69-75.
-
(2003)
Cerebrovasc Dis
, vol.16
, pp. 69-75
-
-
Dawson, S.L.1
Panerai, R.B.2
Potter, J.F.3
-
16
-
-
84655167777
-
Salvinorin A Pretreatment Preserves Cerebrovascular Autoregulation After Brain Hypoxic/Ischemic Injury via Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase in Piglets
-
Su D, Riley J, Armstead WM, Liu R, (2012) Salvinorin A Pretreatment Preserves Cerebrovascular Autoregulation After Brain Hypoxic/Ischemic Injury via Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase in Piglets. Anesth Analg 114: 200-204.
-
(2012)
Anesth Analg
, vol.114
, pp. 200-204
-
-
Su, D.1
Riley, J.2
Armstead, W.M.3
Liu, R.4
-
17
-
-
2542506670
-
Long-term functional outcome of pediatric stroke survivors
-
Hurvitz E, Warschausky S, Berg M, Tsai S, (2004) Long-term functional outcome of pediatric stroke survivors. Top Stroke Rehabil 11: 51-59.
-
(2004)
Top Stroke Rehabil
, vol.11
, pp. 51-59
-
-
Hurvitz, E.1
Warschausky, S.2
Berg, M.3
Tsai, S.4
-
18
-
-
0037378589
-
Prognosis of haemorrhagic stroke in childhood: a long-term follow-up study
-
Blom I, De Schryver EL, Kappelle LJ, Rinkel GJ, Jennekens-Schinkel A, et al. (2003) Prognosis of haemorrhagic stroke in childhood: a long-term follow-up study. Dev Med Child Neurol 45: 233-239.
-
(2003)
Dev Med Child Neurol
, vol.45
, pp. 233-239
-
-
Blom, I.1
De Schryver, E.L.2
Kappelle, L.J.3
Rinkel, G.J.4
Jennekens-Schinkel, A.5
-
19
-
-
78650516001
-
New insights (and new interrogations) in perinatal arterial ischemic stroke
-
Chabrier S, Husson B, Dinomais M, Landrieu P, Nguyen The Tich S, (2011) New insights (and new interrogations) in perinatal arterial ischemic stroke. Thromb Res 127: 13-22.
-
(2011)
Thromb Res
, vol.127
, pp. 13-22
-
-
Chabrier, S.1
Husson, B.2
Dinomais, M.3
Landrieu, P.4
Nguyen The Tich, S.5
-
20
-
-
0034746189
-
The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling
-
Nicole O, Docagne F, Ali C, Margaill I, Carmeliet P, et al. (2001) The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med 7: 59-64.
-
(2001)
Nat Med
, vol.7
, pp. 59-64
-
-
Nicole, O.1
Docagne, F.2
Ali, C.3
Margaill, I.4
Carmeliet, P.5
-
21
-
-
79851508084
-
tPA contributes to impairment of ATP and Ca sensitive K channel mediated cerebrovasodilation after hypoxia/ischemia through upregulation of ERK MAPK
-
Armstead WM, Riley J, Cines DB, Higazi AA, (2011) tPA contributes to impairment of ATP and Ca sensitive K channel mediated cerebrovasodilation after hypoxia/ischemia through upregulation of ERK MAPK. Brain Res 1376: 88-93.
-
(2011)
Brain Res
, vol.1376
, pp. 88-93
-
-
Armstead, W.M.1
Riley, J.2
Cines, D.B.3
Higazi, A.A.4
-
22
-
-
0027218469
-
Neuroprotective effect of the kappa-agonist enadoline (CI-977) in rat models of focal cerebral ischaemia
-
Hayward NJ, McKnight AT, Woodruff GN, (1993) Neuroprotective effect of the kappa-agonist enadoline (CI-977) in rat models of focal cerebral ischaemia. Eur J Neurosci 5: 961-967.
-
(1993)
Eur J Neurosci
, vol.5
, pp. 961-967
-
-
Hayward, N.J.1
McKnight, A.T.2
Woodruff, G.N.3
-
23
-
-
2142698060
-
Prolonged opportunity for ischemic neuroprotection with selective kappa-opioid receptor agonist in rats
-
Chen TY, Goyagi T, Toung TJ, Kirsch JR, Hurn PD, et al. (2004) Prolonged opportunity for ischemic neuroprotection with selective kappa-opioid receptor agonist in rats. Stroke 35: 1180-1185.
-
(2004)
Stroke
, vol.35
, pp. 1180-1185
-
-
Chen, T.Y.1
Goyagi, T.2
Toung, T.J.3
Kirsch, J.R.4
Hurn, P.D.5
-
24
-
-
0037015067
-
Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist
-
Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, et al. (2002) Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proc Natl Acad Sci U S A 99: 11934-11939.
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, pp. 11934-11939
-
-
Roth, B.L.1
Baner, K.2
Westkaemper, R.3
Siebert, D.4
Rice, K.C.5
-
25
-
-
33749671701
-
Salvinorin A: from natural product to human therapeutics
-
Vortherms TA, Roth BL, (2006) Salvinorin A: from natural product to human therapeutics. Mol Interv 6: 257-265.
-
(2006)
Mol Interv
, vol.6
, pp. 257-265
-
-
Vortherms, T.A.1
Roth, B.L.2
-
26
-
-
0141962563
-
Acute physiologic and chronic histologic changes in rats and mice exposed to the unique hallucinogen salvinorin A
-
Mowry M, Mosher M, Briner W, (2003) Acute physiologic and chronic histologic changes in rats and mice exposed to the unique hallucinogen salvinorin A. J Psychoactive Drugs 35: 379-382.
-
(2003)
J Psychoactive Drugs
, vol.35
, pp. 379-382
-
-
Mowry, M.1
Mosher, M.2
Briner, W.3
-
27
-
-
59649116688
-
Unconditioned behavioral effects of the powerful kappa-opioid hallucinogen salvinorin A in nonhuman primates: fast onset and entry into cerebrospinal fluid
-
Butelman ER, Prisinzano TE, Deng H, Rus S, Kreek MJ, (2009) Unconditioned behavioral effects of the powerful kappa-opioid hallucinogen salvinorin A in nonhuman primates: fast onset and entry into cerebrospinal fluid. J Pharmacol Exp Ther 328: 588-597.
-
(2009)
J Pharmacol Exp Ther
, vol.328
, pp. 588-597
-
-
Butelman, E.R.1
Prisinzano, T.E.2
Deng, H.3
Rus, S.4
Kreek, M.J.5
-
28
-
-
44449102022
-
Pharmacokinetics of the potent hallucinogen, salvinorin A in primates parallels the rapid onset and short duration of effects in humans
-
Hooker JM, Xu Y, Schiffer W, Shea C, Carter P, et al. (2008) Pharmacokinetics of the potent hallucinogen, salvinorin A in primates parallels the rapid onset and short duration of effects in humans. NeuroImage 41: 1044-1050.
-
(2008)
NeuroImage
, vol.41
, pp. 1044-1050
-
-
Hooker, J.M.1
Xu, Y.2
Schiffer, W.3
Shea, C.4
Carter, P.5
-
29
-
-
67349111280
-
Evaluation of the transport, in vitro metabolism and pharmacokinetics of Salvinorin A, a potent hallucinogen
-
Teksin ZS, Lee IJ, Nemieboka NN, Othman AA, Upreti VV, et al. (2009) Evaluation of the transport, in vitro metabolism and pharmacokinetics of Salvinorin A, a potent hallucinogen. Eur J Pharm Biopharm 72: 471-477.
-
(2009)
Eur J Pharm Biopharm
, vol.72
, pp. 471-477
-
-
Teksin, Z.S.1
Lee, I.J.2
Nemieboka, N.N.3
Othman, A.A.4
Upreti, V.V.5
-
30
-
-
70350166693
-
Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents
-
Braida D, Capurro V, Zani A, Rubino T, Vigano D, et al. (2009) Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents. Br J Pharmacol 157: 844-853.
-
(2009)
Br J Pharmacol
, vol.157
, pp. 844-853
-
-
Braida, D.1
Capurro, V.2
Zani, A.3
Rubino, T.4
Vigano, D.5
-
31
-
-
4544381116
-
Salvinorin A: a novel and highly selective kappa-opioid receptor agonist
-
Yan F, Roth BL, (2004) Salvinorin A: a novel and highly selective kappa-opioid receptor agonist. Life Sci 75: 2615-2619.
-
(2004)
Life Sci
, vol.75
, pp. 2615-2619
-
-
Yan, F.1
Roth, B.L.2
-
33
-
-
0033843407
-
Activation of mitogen-activated protein kinases after permanent cerebral artery occlusion in mouse brain
-
Wu DC, Ye W, Che XM, Yang GY, (2000) Activation of mitogen-activated protein kinases after permanent cerebral artery occlusion in mouse brain. J Cereb Blood Flow Metab 20: 1320-1330.
-
(2000)
J Cereb Blood Flow Metab
, vol.20
, pp. 1320-1330
-
-
Wu, D.C.1
Ye, W.2
Che, X.M.3
Yang, G.Y.4
-
34
-
-
50649113476
-
uPA impairs cerebrovasodilation after hypoxia/ischemia through LRP and ERK MAPK
-
Armstead WM, Cines DB, Bdeir K, Kulikovskaya I, Stein SC, et al. (2008) uPA impairs cerebrovasodilation after hypoxia/ischemia through LRP and ERK MAPK. Brain Res 1231: 121-131.
-
(2008)
Brain Res
, vol.1231
, pp. 121-131
-
-
Armstead, W.M.1
Cines, D.B.2
Bdeir, K.3
Kulikovskaya, I.4
Stein, S.C.5
-
35
-
-
0346851953
-
A neuroprotective role of extracellular signal-regulated kinase in N-acetyl-O-methyldopamine-treated hippocampal neurons after exposure to in vitro and in vivo ischemia
-
Park EM, Joh TH, Volpe BT, Chu CK, Song G, et al. (2004) A neuroprotective role of extracellular signal-regulated kinase in N-acetyl-O-methyldopamine-treated hippocampal neurons after exposure to in vitro and in vivo ischemia. Neuroscience 123: 147-154.
-
(2004)
Neuroscience
, vol.123
, pp. 147-154
-
-
Park, E.M.1
Joh, T.H.2
Volpe, B.T.3
Chu, C.K.4
Song, G.5
-
36
-
-
0037216665
-
Significant neuroprotection against ischemic brain injury by inhibition of the MEK1 protein kinase in mice: exploration of potential mechanism associated with apoptosis
-
Wang X, Wang H, Xu L, Rozanski DJ, Sugawara T, et al. (2003) Significant neuroprotection against ischemic brain injury by inhibition of the MEK1 protein kinase in mice: exploration of potential mechanism associated with apoptosis. J Pharmacol Exp Ther 304: 172-178.
-
(2003)
J Pharmacol Exp Ther
, vol.304
, pp. 172-178
-
-
Wang, X.1
Wang, H.2
Xu, L.3
Rozanski, D.J.4
Sugawara, T.5
-
37
-
-
84857064712
-
Neuroprotective effects of remifentanil against transient focal cerebral ischemia in rats
-
Jeong S, Kim SJ, Jeong C, Lee S, Jeong H, et al. (2012) Neuroprotective effects of remifentanil against transient focal cerebral ischemia in rats. J Neurosurg Anesthesiol 24: 51-57.
-
(2012)
J Neurosurg Anesthesiol
, vol.24
, pp. 51-57
-
-
Jeong, S.1
Kim, S.J.2
Jeong, C.3
Lee, S.4
Jeong, H.5
-
38
-
-
78650891600
-
Blockade of the MEK/ERK pathway with a raf inhibitor prevents activation of pro-inflammatory mediators in cerebral arteries and reduction in cerebral blood flow after subarachnoid hemorrhage in a rat model
-
Maddahi A, Ansar S, Chen Q, Edvinsson L, (2011) Blockade of the MEK/ERK pathway with a raf inhibitor prevents activation of pro-inflammatory mediators in cerebral arteries and reduction in cerebral blood flow after subarachnoid hemorrhage in a rat model. J Cereb Blood Flow Metab 31: 144-154.
-
(2011)
J Cereb Blood Flow Metab
, vol.31
, pp. 144-154
-
-
Maddahi, A.1
Ansar, S.2
Chen, Q.3
Edvinsson, L.4
-
39
-
-
0033607259
-
MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia
-
Alessandrini A, Namura S, Moskowitz MA, Bonventre JV, (1999) MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia. Proc Natl Acad Sci U S A 96: 12866-12869.
-
(1999)
Proc Natl Acad Sci U S A
, vol.96
, pp. 12866-12869
-
-
Alessandrini, A.1
Namura, S.2
Moskowitz, M.A.3
Bonventre, J.V.4
-
40
-
-
77349102966
-
Exercise preconditioning reduces neuronal apoptosis in stroke by up-regulating heat shock protein-70 (heat shock protein-72) and extracellular-signal-regulated-kinase 1/2
-
Liebelt B, Papapetrou P, Ali A, Guo M, Ji X, et al. (2010) Exercise preconditioning reduces neuronal apoptosis in stroke by up-regulating heat shock protein-70 (heat shock protein-72) and extracellular-signal-regulated-kinase 1/2. Neuroscience 166: 1091-1100.
-
(2010)
Neuroscience
, vol.166
, pp. 1091-1100
-
-
Liebelt, B.1
Papapetrou, P.2
Ali, A.3
Guo, M.4
Ji, X.5
-
41
-
-
33750443222
-
Ischemic preconditioning-induced activation of ERK1/2 in the rat hippocampus
-
Choi JS, Kim HY, Cha JH, Lee MY, (2006) Ischemic preconditioning-induced activation of ERK1/2 in the rat hippocampus. Neurosci Lett 409: 187-191.
-
(2006)
Neurosci Lett
, vol.409
, pp. 187-191
-
-
Choi, J.S.1
Kim, H.Y.2
Cha, J.H.3
Lee, M.Y.4
|